{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:58:50Z","timestamp":1790384330471,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Zhejiang University of Chinese Medicine's School-level Research Project Affiliated Hospital Research Special Project","award":["2023FSYYZY10"],"award-info":[{"award-number":["2023FSYYZY10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00405-026-10354-1","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:52:46Z","timestamp":1780293166000},"page":"5499-5511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of the efficacy of different pharmacological treatments for laryngopharyngeal reflux: a systematic review and network meta-analysis"],"prefix":"10.1007","volume":"283","author":[{"given":"Wen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liman","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0144-7442","authenticated-orcid":false,"given":"Jihong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"10354_CR1","doi-asserted-by":"publisher","unstructured":"Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101:1900-1920; quiz 1943. https:\/\/doi.org\/10.1016\/10.1111\/j.1572-0241.2006.00630.x","DOI":"10.1016\/10.1111\/j.1572-0241.2006.00630.x"},{"key":"10354_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.14728","volume":"1510","author":"AJ Krause","year":"2022","unstructured":"Krause AJ, Walsh EH, Weissbrod PA, Taft TH, Yadlapati R (2022) An update on current treatment strategies for laryngopharyngeal reflux symptoms. Ann N Y Acad Sci 1510:5\u201317. https:\/\/doi.org\/10.1111\/nyas.14728","journal-title":"Ann N Y Acad Sci"},{"key":"10354_CR3","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/10.1002\/lary.31134","volume":"134","author":"JR Lechien","year":"2024","unstructured":"Lechien JR, Vaezi MF, Chan WW, Allen JE, Karkos PD, Saussez S et al (2024) The Dubai definition and diagnostic criteria of Laryngopharyngeal reflux: The IFOS Consensus. Laryngoscope 134:1614\u20131624. https:\/\/doi.org\/10.1016\/10.1002\/lary.31134","journal-title":"Laryngoscope"},{"key":"10354_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.21053\/ceo.2017.00577","volume":"11","author":"JS Lee","year":"2018","unstructured":"Lee JS, Jung AR, Park JM, Park MJ, Lee YC, Eun YG (2018) Comparison of characteristics according to reflux type in patients with laryngopharyngeal reflux. Clin Exp Otorhinolaryngol 11:141\u2013145. https:\/\/doi.org\/10.21053\/ceo.2017.00577","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"10354_CR5","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/10.1002\/lary.27591","volume":"129","author":"JR Lechien","year":"2019","unstructured":"Lechien JR, Saussez S, Schindler A, Karkos PD, Hamdan AL, Harmegnies B et al (2019) Clinical outcomes of Laryngopharyngeal reflux treatment: a systematic review and meta-analysis. Laryngoscope 129:1174\u20131187. https:\/\/doi.org\/10.1016\/10.1002\/lary.27591","journal-title":"Laryngoscope"},{"key":"10354_CR6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/10.1001\/jamaoto.2019.0315","volume":"145","author":"JR Lechien","year":"2019","unstructured":"Lechien JR, Dapri G, Dequanter D, Rodriguez Ruiz A, Marechal MT, De Marrez LG et al (2019) Surgical treatment for Laryngopharyngeal reflux disease: a systematic review. JAMA Otolaryngol Head Neck Surg 145:655\u2013666. https:\/\/doi.org\/10.1016\/10.1001\/jamaoto.2019.0315","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10354_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00405-008-0708-7","volume":"266","author":"JA McGlashan","year":"2009","unstructured":"McGlashan JA, Johnstone LM, Sykes J, Strugala V, Dettmar PW (2009) The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux. Eur Arch Otorhinolaryngol 266:243\u2013251. https:\/\/doi.org\/10.1007\/s00405-008-0708-7","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"10","key":"10354_CR8","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1007\/s00405-018-5079-0","volume":"275","author":"MD Wilkie","year":"2018","unstructured":"Wilkie MD, Fraser HM, Raja H (2018) Gaviscon\u00ae Advance alone versus co-prescription of Gaviscon\u00ae Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux. Eur Arch Otorhinolaryngol 275(10):2515\u20132521. https:\/\/doi.org\/10.1007\/s00405-018-5079-0","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10354_CR9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/apt.12857","volume":"40","author":"A De Ruigh","year":"2014","unstructured":"De Ruigh A, Roman S, Chen J, Pandolfino JE, Kahrilas PJ (2014) Gaviscon Double Action Liquid (antacid & alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover study. Aliment Pharmacol Ther 40:531\u2013537. https:\/\/doi.org\/10.1111\/apt.12857","journal-title":"Aliment Pharmacol Ther"},{"key":"10354_CR10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1046\/j.1365-2036.2000.00759.x","volume":"14","author":"KG Mandel","year":"2000","unstructured":"Mandel KG, Daggy BP, Brodie DA, Jacoby HI (2000) Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Aliment Pharmacol Ther 14:669\u2013690. https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00759.x","journal-title":"Aliment Pharmacol Ther"},{"key":"10354_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/10.3748\/wjg.v12.i5.747","volume":"12","author":"IR Lai","year":"2006","unstructured":"Lai IR, Wu MS, Lin JT (2006) Prospective, randomized, and active controlled study of the efficacy of alginic acid and antacid in the treatment of patients with endoscopy-negative reflux disease. World J Gastroenterol 12:747\u2013754. https:\/\/doi.org\/10.1016\/10.3748\/wjg.v12.i5.747","journal-title":"World J Gastroenterol"},{"key":"10354_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/10.23812\/21-1supp2-12","volume":"35","author":"G Ciprandi","year":"2021","unstructured":"Ciprandi G, Damiani V, Passali FM, Crisanti A, Motta G, Passali D (2021) Magnesium alginate in patients with laryngopharyngeal reflux. J Biol Regul Homeost Agents 35:61\u201364. https:\/\/doi.org\/10.1016\/10.23812\/21-1supp2-12","journal-title":"J Biol Regul Homeost Agents"},{"key":"10354_CR13","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/10.1097\/MLG.0b013e3181651c3a","volume":"118","author":"bJ Jin","year":"2008","unstructured":"Jin bJ, Lee YS, Jeong SW, Jeong JH, Lee SH, Tae K (2008) Change of acoustic parameters before and after treatment in laryngopharyngeal reflux patients. Laryngoscope 118:938\u2013941. https:\/\/doi.org\/10.1016\/10.1097\/MLG.0b013e3181651c3a","journal-title":"Laryngoscope"},{"key":"10354_CR14","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/10.1053\/j.gastro.2024.06.038","volume":"167","author":"A Patel","year":"2024","unstructured":"Patel A, Laine L, Moayyedi P, Wu J (2024) AGA clinical practice update on integrating Potassium-competitive acid blockers into clinical practice: expert review. Gastroenterology 167:1228\u20131238. https:\/\/doi.org\/10.1016\/10.1053\/j.gastro.2024.06.038","journal-title":"Gastroenterology"},{"key":"10354_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/10.1111\/apt.17269","volume":"57","author":"S Pomenti","year":"2023","unstructured":"Pomenti S, Katzka DA (2023) Editorial: P-CABs for treatment of reflux oesophagitis-is this the future? Aliment Pharmacol Ther 57:146\u2013147. https:\/\/doi.org\/10.1016\/10.1111\/apt.17269","journal-title":"Aliment Pharmacol Ther"},{"key":"10354_CR16","doi-asserted-by":"publisher","first-page":"Jc76","DOI":"10.1016\/10.7326\/annals-24-00741-jc","volume":"177","author":"SV van Zanten","year":"2024","unstructured":"van Zanten SV (2024) In grade C\/D erosive esophagitis, vonoprazan ranks highest among PPIs and P-CABs for healing and maintaining remission. Ann Intern Med 177:Jc76. https:\/\/doi.org\/10.1016\/10.7326\/annals-24-00741-jc","journal-title":"Ann Intern Med"},{"key":"10354_CR17","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1016\/10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj 366:l4898. https:\/\/doi.org\/10.1016\/10.1136\/bmj.l4898","journal-title":"Bmj"},{"key":"10354_CR18","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/10.1016\/j.jvoice.2024.12.031","volume":"39","author":"C Bian","year":"2025","unstructured":"Bian C, Shen P, Zang Y, Liu W, Zhou P (2025) Vonoprazan Fumarate: a promising therapeutic option for the rapid relief of Laryngopharyngeal Reflux Disease. J Voice 39:862\u2013868. https:\/\/doi.org\/10.1016\/10.1016\/j.jvoice.2024.12.031","journal-title":"J Voice"},{"key":"10354_CR19","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/10.1111\/coa.13737","volume":"46","author":"SM Ceylan","year":"2021","unstructured":"Ceylan SM, Kanmaz MA, Disikirik I, Karadeniz PG (2021) Peak nasal inspiratory airflow measurements for assessing laryngopharyngeal reflux treatment. Clin Otolaryngol 46:796\u2013801. https:\/\/doi.org\/10.1016\/10.1111\/coa.13737","journal-title":"Clin Otolaryngol"},{"key":"10354_CR20","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/10.1177\/0003489420913592","volume":"129","author":"M Chae","year":"2020","unstructured":"Chae M, Jang DH, Kim HC, Kwon M (2020) A prospective randomized clinical trial of combination therapy with proton pump inhibitors and mucolytics in patients with laryngopharyngeal reflux. Ann Otol Rhinol Laryngol 129:781\u2013787. https:\/\/doi.org\/10.1016\/10.1177\/0003489420913592","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10354_CR21","first-page":"757","volume":"51","author":"P Dabirmoghaddam","year":"2013","unstructured":"Dabirmoghaddam P, Amali A, Motiee Langroudi M, SamavatiFard MR, Hejazi M, Sharifian Razavi M (2013) The effect of N-acetyl cysteine on laryngopharyngeal reflux. Acta Med Iran 51:757\u2013764","journal-title":"Acta Med Iran"},{"key":"10354_CR22","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/10.1001\/jamaoto.2016.4127","volume":"143","author":"E Dagli","year":"2017","unstructured":"Dagli E, Y\u00fcksel A, Kaya M, Ugur KS, Turkay FC (2017) Association of oral antireflux medication with laryngopharyngeal reflux and nasal resistance. JAMA Otolaryngol Head Neck Surg 143:478\u2013483. https:\/\/doi.org\/10.1016\/10.1001\/jamaoto.2016.4127","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10354_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/10.47009\/jamp.2023.5.1.26","volume":"5","author":"SS Devi","year":"2023","unstructured":"Devi SS, Karam M, Singh NK, Anand AB, Dimngel S, Potsangbam DS (2023) Clinical features and treatment modalities of laryngopharungeal reflux: a randomized controlled sutdy. Int J Acad Med Pharm 5:123\u2013126. https:\/\/doi.org\/10.1016\/10.47009\/jamp.2023.5.1.26","journal-title":"Int J Acad Med Pharm"},{"key":"10354_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/10.5005\/jp-journals-10003-1186","volume":"7","author":"K Doshi","year":"2015","unstructured":"Doshi K, Varghese A, Badyal DK (2015) Evaluation of omeprazole in the treatment of laryngopharyngeal reflux disease: a single center, prospective and randomized study. Int J Otorhinolaryngol Clin 7:45\u201350. https:\/\/doi.org\/10.1016\/10.5005\/jp-journals-10003-1186","journal-title":"Int J Otorhinolaryngol Clin"},{"key":"10354_CR25","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/10.3760\/cma.j.cn115330-20220216-00069","volume":"57","author":"HL Han","year":"2022","unstructured":"Han HL, Lyu QP (2022) [The preliminary application of vonoprazan fumarate on laryngopharyngeal reflux disease]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 57:1323\u20131327. https:\/\/doi.org\/10.1016\/10.3760\/cma.j.cn115330-20220216-00069","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"10354_CR26","first-page":"73","volume":"95","author":"N Hunchaisri","year":"2012","unstructured":"Hunchaisri N (2012) Treatment of laryngopharyngeal reflux: a comparison between domperidone plus omeprazole and omeprazole alone. J Med Assoc Thai 95:73\u201380","journal-title":"J Med Assoc Thai"},{"key":"10354_CR27","doi-asserted-by":"publisher","first-page":"6116","DOI":"10.1016\/10.3390\/jcm12196116","volume":"12","author":"HK Jeon","year":"2023","unstructured":"Jeon HK, Kim GH, Cheon YI, Shin SC, Lee BJ (2023) Efficacy of tegoprazan in patients with laryngopharyngeal reflux disease: a preliminary feasibility study. J Clin Med 12:6116. https:\/\/doi.org\/10.1016\/10.3390\/jcm12196116","journal-title":"J Clin Med"},{"key":"10354_CR28","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/10.1016\/j.jvoice.2019.11.017","volume":"35","author":"YS Jo","year":"2021","unstructured":"Jo YS, Choi IS, So YK (2021) The use of inhaled N-Acetylcysteine for laryngopharyngeal reflux disease: a randomized controlled trial. J Voice 35:618\u2013624. https:\/\/doi.org\/10.1016\/10.1016\/j.jvoice.2019.11.017","journal-title":"J Voice"},{"key":"10354_CR29","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1016\/10.1007\/s00405-024-08877-6","volume":"281","author":"SI Kim","year":"2024","unstructured":"Kim SI, Lee YC, Cha W, Jung AR, Jang JY, Choi JS et al (2024) Efficacy and safety of fexuprazan in patients with symptoms and signs of laryngopharyngeal reflux disease: a randomized clinical trial. Eur Arch Otorhinolaryngol 281:5873\u20135883. https:\/\/doi.org\/10.1016\/10.1007\/s00405-024-08877-6","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10354_CR30","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/10.1016\/j.cgh.2010.03.009","volume":"8","author":"PK Lam","year":"2010","unstructured":"Lam PK, Ng ML, Cheung TK, Wong BY, Tan VP, Fong DY et al (2010) Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial. Clin Gastroenterol Hepatol 8:770\u2013776. https:\/\/doi.org\/10.1016\/10.1016\/j.cgh.2010.03.009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10354_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/10.18787\/jr.2023.00052","volume":"30","author":"JY Lee","year":"2023","unstructured":"Lee JY, Kang SH, Cho MJ, Jung HJ (2023) Effects of a proton-pump inhibitor on postnasal drip symptoms in patients with laryngopharyngeal reflux. J Rhinol 30:139\u2013143. https:\/\/doi.org\/10.1016\/10.18787\/jr.2023.00052","journal-title":"J Rhinol"},{"key":"10354_CR32","first-page":"997","volume":"29","author":"H Luo","year":"2015","unstructured":"Luo H, Ma S, Gao Y, Yan J, Hou J, Xu M (2015) The therapeutic effect of proton pump inhibitor on alleviation of hoarseness symptoms in patients with laryngopharyngeal reflux. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 29:997\u20131001","journal-title":"Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"10354_CR33","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/10.1007\/s12070-020-02005-6","volume":"74","author":"AS Mathew","year":"2022","unstructured":"Mathew AS, Shilpa H (2022) Is adjunctive alginate therapy beneficial in the treatment of laryngopharyngeal reflux disease in a rural Indian population? A prospective randomized study. Indian J Otolaryngol Head Neck Surg 74:2104\u20132110. https:\/\/doi.org\/10.1016\/10.1007\/s12070-020-02005-6","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10354_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/10.37290\/ctnr2641-452X.23:43-49","volume":"23","author":"A Monda","year":"2025","unstructured":"Monda A, Genchi G, Barbara F, Cariti F, Russo C, Ciccarone S et al (2025) The effects of the combination of Hyaluronic acid, Malva sylvestris, and Sodium alginate on the Pharyngolaryngeal reflux: a randomized case-control study. Curr Tops Nutraceutical Res 23:43. https:\/\/doi.org\/10.1016\/10.37290\/ctnr2641-452X.23:43-49","journal-title":"Curr Tops Nutraceutical Res"},{"key":"10354_CR35","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/10.1007\/s00405-021-07219-0","volume":"279","author":"N Pizzorni","year":"2022","unstructured":"Pizzorni N, Ambrogi F, Eplite A, Rama S, Robotti C, Lechien J et al (2022) Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial. Eur Arch Otorhinolaryngol 279:2533\u20132542. https:\/\/doi.org\/10.1016\/10.1007\/s00405-021-07219-0","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10354_CR36","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/10.1016\/j.otohns.2008.06.003","volume":"139","author":"O Reichel","year":"2008","unstructured":"Reichel O, Dressel H, Wieder\u00e4nders K, Issing WJ (2008) Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux. Otolaryngol Head Neck Surg 139:414\u2013420. https:\/\/doi.org\/10.1016\/10.1016\/j.otohns.2008.06.003","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10354_CR37","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/10.1007\/s00405-012-2341-8","volume":"270","author":"BJ Chun","year":"2013","unstructured":"Chun BJ, Lee DS (2013) The effect of itopride combined with lansoprazole in patients with laryngopharyngeal reflux disease. Eur Arch Otorhinolaryngol 270:1385\u20131390. https:\/\/doi.org\/10.1016\/10.1007\/s00405-012-2341-8","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10354_CR38","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1016\/10.1016\/s1590-8658(19)30259-2","volume":"51","author":"F Ingravalle","year":"2019","unstructured":"Ingravalle F, Tosetti C, Benedetto E, Casella G, Zamparella M, Gambaro P et al (2019) P.01.9 Effectiveness of PEPSINO\u00ae, a novel medical device containing hyaluronic acid and alginate, for the treatment of Laryngopharyngeal reflux symptoms. Dig Liver Dis 51:e136\u2013e137. https:\/\/doi.org\/10.1016\/10.1016\/s1590-8658(19)30259-2","journal-title":"Dig Liver Dis"},{"key":"10354_CR39","doi-asserted-by":"publisher","first-page":"E349","DOI":"10.1016\/10.1002\/lary.27185","volume":"128","author":"JR Lechien","year":"2018","unstructured":"Lechien JR, Karkos PD, Harmegnies B, Saussez S (2018) In response to double-blind, placebo-controlled study with alginate suspension for laryngopharyngeal reflux disease. Laryngoscope 128:E349-e350. https:\/\/doi.org\/10.1016\/10.1002\/lary.27185","journal-title":"Laryngoscope"},{"key":"10354_CR40","first-page":"S159","volume":"100","author":"A Santeerapharp","year":"2017","unstructured":"Santeerapharp A, Wiryaamornchai P, Hunchaisri N (2017) Comparison between omeprazole plus baclofen and omeprazole plus placebo in the treatment of laryngopharyngeal reflux. J Med Assoc Thai 100:S159\u2013S164","journal-title":"J Med Assoc Thai"},{"key":"10354_CR41","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/10.1111\/coa.12358","volume":"40","author":"M Sereg-Bahar","year":"2015","unstructured":"Sereg-Bahar M, Jerin A, Jansa R, Stabuc B, Hocevar-Boltezar I (2015) Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux - a prospective comparative study. Clin Otolaryngol 40:234\u2013239. https:\/\/doi.org\/10.1016\/10.1111\/coa.12358","journal-title":"Clin Otolaryngol"},{"key":"10354_CR42","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/10.1001\/jama.294.12.1534","volume":"294","author":"CN Ford","year":"2005","unstructured":"Ford CN (2005) Evaluation and management of laryngopharyngeal reflux. JAMA 294:1534\u20131540. https:\/\/doi.org\/10.1016\/10.1001\/jama.294.12.1534","journal-title":"JAMA"},{"key":"10354_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/10.1007\/s11894-024-00939-3","volume":"26","author":"C Scarpignato","year":"2024","unstructured":"Scarpignato C, Hunt RH (2024) Potassium-competitive acid blockers: current clinical use and future developments. Curr Gastroenterol Rep 26:273\u2013293. https:\/\/doi.org\/10.1016\/10.1007\/s11894-024-00939-3","journal-title":"Curr Gastroenterol Rep"},{"key":"10354_CR44","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/10.1097\/MOG.0b013e32834bd53f","volume":"27","author":"ML Schubert","year":"2011","unstructured":"Schubert ML (2011) Gastric secretion. Curr Opin Gastroenterol 27:536\u2013542. https:\/\/doi.org\/10.1016\/10.1097\/MOG.0b013e32834bd53f","journal-title":"Curr Opin Gastroenterol"},{"key":"10354_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/10.5056\/jnm24159","volume":"31","author":"GH Kim","year":"2025","unstructured":"Kim GH, Fass R (2025) Potassium-competitive acid blockers for treatment of extraesophageal symptoms and signs. J Neurogastroenterol Motil 31:170\u2013177. https:\/\/doi.org\/10.1016\/10.5056\/jnm24159","journal-title":"J Neurogastroenterol Motil"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10354-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:03:50Z","timestamp":1790381030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-026-10354-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10354"],"URL":"https:\/\/doi.org\/10.1007\/s00405-026-10354-1","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This is a systematic review and meta-analysis. Hence, ethical approval was not required for the study.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}